background image

Paid Clinical Trials Phoenix

Discover 1,279 paid clinical trials in Phoenix, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine

Recruiting
PHASE3

Sponsor:

Eli Lilly and Company

Location:

Phoenix AZ, Tucson AZ, San Diego CA, Ontario CAshow 41 more

Code:

NCT04616326

Conditions

Chronic Migraine

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

Galcanezumab

Placebo

Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease

Recruiting

Sponsor:

AbbVie

Location:

Sun City AZ, Las Vegas NV, Palo Alto CA, San Antonio TXshow 15 more

Code:

NCT06107426

Conditions

Parkinson's Disease (PD)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

A Study of the Natural History of Participants With LGMD2E/R4, LGMD2D/R3, LGMD2C/R5, and LGMD2A/R1 ≥ 4 Years of Age, Who Are Managed in Routine Clinical Practice

Recruiting

Sponsor:

Sarepta Therapeutics, Inc.

Location:

Phoenix AZ, La Jolla CA, Salt Lake City UT, Sacramento CAshow 8 more

Code:

NCT04475926

Conditions

Limb-girdle Muscular Dystrophy

Eligibility Criteria

Sex: All

Age: 4+

Healthy Volunteers: Not accepted

A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs

Recruiting
PHASE1
PHASE2

Sponsor:

Krystal Biotech, Inc.

Location:

Scottsdale AZ, El Paso TX, The Woodlands TX, New Orleans LAshow 4 more

Code:

NCT06228326

Conditions

Lung Cancer, Non-small Cell

Lung Cancer Metastatic

Solid Tumor, Adult

Advanced Cancer

Lung Cancer (NSCLC)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

KB707

Pembrolizumab (KEYTRUDA®)

Chemotherapy

Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma

Recruiting
PHASE1
PHASE2

Sponsor:

C4 Therapeutics, Inc.

Location:

Phoenix AZ, Denver CO, San Francisco CA, Saint Louis MOshow 7 more

Code:

NCT04756726

Conditions

Multiple Myeloma

Lymphoma, Non-Hodgkin's

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

cemsidomide

Dexamethasone Oral

A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)

Recruiting
PHASE3

Sponsor:

Eli Lilly and Company

Location:

Phoenix AZ, Mesa AZ, Tucson AZ, Henderson NVshow 172 more

Code:

NCT05026866

Conditions

Alzheimer Disease

Eligibility Criteria

Sex: All

Age: 65 - 70+

Healthy Volunteers: Not accepted

Interventions

Donanemab

Placebo

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting
PHASE3

Sponsor:

NRG Oncology

Location:

Phoenix AZ, Kingman AZ, Henderson NV, Rancho Mirage CAshow 706 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

Trial of 225Ac-DOTATATE (RYZ101) in Subjects with ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.

Recruiting
PHASE1
PHASE2

Sponsor:

RayzeBio, Inc.

Location:

Phoenix AZ, Irvine CA, Santa Monica CA, Salt Lake City UTshow 18 more

Code:

NCT06590857

Conditions

Metastatic Breast Cancer

HER2-negative Breast Cancer

ER+ Breast Cancer

Advanced Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

RYZ101

A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma

Recruiting
PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Phoenix AZ, Mesa AZ, San Diego CA, Loma Linda CAshow 103 more

Code:

NCT03871257

Conditions

Low Grade Glioma

Neurofibromatosis Type 1

Visual Pathway Glioma

Eligibility Criteria

Sex: All

Age: 2 - 21

Healthy Volunteers: Not accepted

Interventions

Carboplatin

Magnetic Resonance Imaging

Quality-of-Life Assessment

Questionnaire Administration

Selumetinib Sulfate

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Recruiting
PHASE3

Sponsor:

Boehringer Ingelheim

Location:

Scottsdale AZ, Tucson AZ, Flagstaff AZ, Las Vegas NVshow 82 more

Code:

NCT06632457

Conditions

Metabolic Dysfunction Associated Steatohepatitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Survodutide

Placebo matching survodutide

With several prominent research institutions and a robust healthcare network, Phoenix stands out as a significant hub for clinical trials. The city hosts leading medical centers such as the Mayo Clinic’s Scottsdale campus, the Translational Genomics Research Institute (TGen), and the Arizona State University (ASU) Biomedical Engineering department. These institutions are at the forefront of advancing clinical research and innovation. The diverse population of Phoenix provides a broad participant base too, enhancing the accuracy and relevance of clinical studies.

Why choose Phoenix for clinical trials?

Common conditions studied in Phoenix

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Phoenix